{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:39:08Z","timestamp":1769081948375,"version":"3.49.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":505,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Plasma volume status (PVS), a measure of plasma volume, has been evaluated as a prognostic marker for chronic heart failure. Although the prognostic value of PVS has been reported, its significance in patients with acute decompensated heart failure (ADHF) admitted to the cardiovascular intensive care unit (CICU) remains unclear. In this study, we examined the relationship between PVS and long-term mortality in patients with ADHF admitted to the CICU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between January 2018 and December 2020, 363 consecutive patients with ADHF were admitted to the Nippon Medical School Hospital CICU. Of the 363 patients, 206 (mean age, 74.9 \u00b1 12.9 years; men, 64.6%) were enrolled in this study. Patients who received red blood cell transfusions, underwent dialysis, were discharged from the CICU or died in the hospital were excluded from the study. We measured the PVS of the patients at admission, transfer to the general ward (GW) and discharge using the Kaplan\u2013Hakim formula. The patients were assigned to four groups according to the quartiles of their PVS measured at each of the three abovementioned timepoints. We examined the association between PVS and all-cause mortality during the observation period (1134 days). The primary endpoint of this study was all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The Kaplan\u2013Meier analysis showed that the high PVS group had a significantly higher mortality rate at admission, transfer to the GW and discharge than the other groups (log-rank test: P = 0.016, P = 0.005 and P &amp;lt; 0.001, respectively). Univariate Cox regression analysis showed that age, body mass index, history of heart failure, use of beta-blockers, albumin level, blood urea nitrogen level, N-terminal pro-brain natriuretic peptide level and left ventricular ejection fraction were significantly different among the PVS groups and thus were not significant prognostic factors for ADHF. Furthermore, the multivariate analysis revealed that PVS at discharge [hazard ratio (HR) = 1.06 (1.00\u20131.12), P = 0.048] was an independent poor prognostic factor for ADHF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights the effect of PVS measured at different timepoints on the prognoses of ADHF patients. Regular assessment of PVS, particularly at discharge, is crucial for optimising patient management and achieving favourable outcomes in cases of ADHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14874","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:54:41Z","timestamp":1716944081000},"page":"1995-2000","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Impact of Plasma Volume Status During Hospital Admission in Patients with Acute Decompensated Heart Failure"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-4614","authenticated-orcid":false,"given":"Yu","family":"Hoshika","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Intensive Care, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Health Care Administration, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Shiomura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Intensive Care, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junsuke","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Intensive Care, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nakata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Intensive Care, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Miyachi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Intensive Care, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Tara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ki","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Intensive Care, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniya","family":"Asai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"2026012113135487000_ehf214874-bib-0001","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/ejhf.193","article-title":"Calculated plasma volume status and prognosis in chronic heart failure","volume":"17","author":"Ling","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026012113135487000_ehf214874-bib-0002","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ejhf.1407","article-title":"Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: Insights from TOPCAT","volume":"21","author":"Grodin","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012113135487000_ehf214874-bib-0003","first-page":"236","volume-title":"Handbook of Dialysis","author":"Hakim","year":"2001","edition":"3rd ed."},{"key":"2026012113135487000_ehf214874-bib-0004","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1177\/2048872617690889","article-title":"Plasma volume status predicts prognosis in patients with acute heart failure syndromes","volume":"7","author":"Yoshihisa","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026012113135487000_ehf214874-bib-0005","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1253\/circrep.CR-19-0039","article-title":"Prognostic value of calculated plasma volume status in patients admitted for acute decompensated heart failure\u2014A prospective comparative study with other indices of plasma volume","volume":"1","author":"Tamaki","year":"2019","journal-title":"Circ Rep"},{"key":"2026012113135487000_ehf214874-bib-0006","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cjco.2019.10.0017","article-title":"Prognostic value of both plasma volume status and nutritional status in patients with severely decompensated acute heart failure","volume":"1","author":"Shirakabe","year":"2019","journal-title":"CJC Open"},{"key":"2026012113135487000_ehf214874-bib-0007","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1069864","article-title":"Effect of estimated plasma volume status and left atrial diameter on prognosis of patients with acute heart failure","volume":"10","author":"Chen","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026012113135487000_ehf214874-bib-0008","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012113135487000_ehf214874-bib-0009","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"JAMA"},{"key":"2026012113135487000_ehf214874-bib-0010","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2026012113135487000_ehf214874-bib-0011","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026012113135487000_ehf214874-bib-0012","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026012113135487000_ehf214874-bib-0013","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s13300-021-01103-0","article-title":"Effect of empagliflozin versus placebo on plasma volume status in patients with acute myocardial infarction and type 2 diabetes mellitus","volume":"12","author":"Hoshika","year":"2021","journal-title":"Diabetes Ther"},{"key":"2026012113135487000_ehf214874-bib-0014","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03769-9","article-title":"Estimated plasma volume status is a modest predictor of true plasma volume excess in compensated chronic heart failure patients","volume":"11","author":"Ahlgrim","year":"2021","journal-title":"Sci Rep"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/4\/1995\/64526725\/eschf_11_4_1995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/4\/1995\/64526725\/eschf_11_4_1995.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:15:37Z","timestamp":1769019337000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/4\/1995\/8271182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5,28]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14874","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"2023-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}